BMRN News
BioMarin Pharmaceutical Inc.
$57.30
+$2.16(+3.92%)
48
Overall
65
Value
27
Tech
52
Quality
Market Cap
$10.67B
Volume
216.80K
52W Range
$49.26 - $70.98
Target Price
$90.77
BMRN news: the latest BioMarin Pharmaceutical Inc. headlines, press releases and market updates, newest first.
Latest BMRN News
- BioMarin Pharmaceutical (BMRN) Initiated with a Buy at UBSTipRanks Auto-Generated Intelligence Newsdesk · Oct 15, 2026
- RBC Capital Keeps Their Hold Rating on BioMarin Pharmaceutical (BMRN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- BioMarin’s Palynziq Desensitization Study Signals Effort to Protect Long‑Term PKU RevenueTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 1, 2026
- BioMarin Grants Ascendis Global License, Secures Royalty RevenuesTipRanks Auto-Generated Newsdesk · Sep 30, 2026
- Biomarin-Linked ENERGY 2 Trial Termination: What It Means for Rare-Disease InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 24, 2026
- BioMarin ends VOXZOGO development for Noonan syndromeTipRanks Auto-Generated Newsdesk · Sep 15, 2026
- Analysts Are Bullish on Top Healthcare Stocks: Corbus Pharmaceuticals (CRBP), BioMarin Pharmaceutical (BMRN)TipRanks Newsroom · Sep 14, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMRN | $57.30 | +3.9% | 216.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioMarin Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW